Pharmaceutical Exporter from India to Algeria.

The Agence Nationale des Produits Pharmaceutiques (ANPP), the National Agency for Pharmaceutical Products, under the Ministry of Pharmaceutical Industry, both created in 2020. Market authorisation is the décision d'enregistrement, granted after review by ANPP's registration commission on a full ICH CTD dossier with CPP, GMP certificates, stability, and labelling. ANPP runs on-site GMP audits, and an imported product needs a local authorised establishment with a pharmacist technical director. M Care prepares the French CTD pack to ANPP expectations and works with the Algerian establishment of record.

Only for molecules that are not yet made locally, and we are honest about that boundary. Algeria runs an aggressive import-substitution regime: a finished product is banned from import once enough local manufacturers exist, and the banned list covers several hundred products and around 180 active ingredients including most common antibiotics, analgesics, antihistamines, and cardiovascular molecules. Local production now covers roughly seventy to eighty percent of the market by volume, and the import bill has been deliberately cut from about USD 1.4 billion in 2022 toward USD 1 billion. The realistic Indian-supply target is therefore specialty, oncology, biologicals, and niche molecules with no adequate local equivalent. M Care checks the banned list before any offer rather than implying open access.

Algeria's rule, in force since 2009 and tightened progressively, is to ban the import of a product once there are local manufacturers producing it, with the working threshold commonly cited at three operating local producers. The prohibited list spans several hundred pharmaceutical products and medical devices and roughly 180 international nonproprietary names. The practical effect is that high-volume commodity generics are largely closed to import, while innovative, specialty, oncology, and biological molecules where local capacity does not yet exist remain importable. Any honest Algeria pitch is built around the products outside the banned list, which is exactly how M Care scopes an enquiry.

A full CTD dossier (Modules 1 to 5) with the Certificate of Pharmaceutical Product, GMP certificates, stability data, and labelling; a local authorised establishment with a pharmacist technical director; and an import permit, the programme or autorisation d'importation, valid one year and renewable. Under Article 30, new import permits are increasingly conditioned on local pharmaceutical investment commitments, a plant, a technical partnership, or a facility upgrade. Post-2020 reform brought registration timelines down to roughly three months for generics and five months for proprietary products, with locally made products getting review priority. From 2025, serialisation is mandatory for all imported human medicines.

The Pharmacie Centrale des Hôpitaux (PCH) is the central hospital pharmacy that procures by public tender and distributes to public hospitals. Local preference is built in: PCH runs national-only tenders for locally made products first, then international tenders with a price preference of around twenty-five percent for local firms. Reimbursement runs through CNAS, the national social-insurance fund, and an imported generic generally qualifies when a same-INN reference is already reimbursed. Imported non-essential products also face a reference-price reduction of about thirty percent against the external basket. M Care bids PCH lots selectively, on molecules where the local-preference and import-ban filters still leave room for an Indian WHO-GMP offer.

Sea freight routes mainly through the Port of Algiers, the country's largest, with Oran as the western secondary gateway, both on the Mediterranean. Transit from Nhava Sheva or Mundra runs roughly eighteen to twenty-two days. Air freight uses Houari Boumediene Airport in Algiers, with cold-chain handled through specialist temperature-controlled forwarders. A real Algerian customs caution: cargo left idle beyond about fifteen days moves to an off-dock bonded terminal, and beyond roughly two months it can be auctioned or destroyed, so fast clearance with complete French documentation and the establishment's import permit in hand is essential. We pre-stage the documentation accordingly.

Arabic is the official language, but French is the working language of Algerian pharmaceutical regulation and medicine, and ANPP dossiers and labelling are handled in French, which suits Indian exporters who already prepare French CTD packs for francophone Africa. M Care assembles the full French CTD, Module 1 administrative content through Module 5, with certified translation, French patient information leaflets, and labelling to ANPP standards. This is the same francophone CTD capability we run for Cameroon, Senegal, and Côte d'Ivoire, applied to Algeria's specific ANPP and serialisation requirements.